Mark Ragosa - 01 Sep 2023 Form 4 Insider Report for Kiniksa Pharmaceuticals, Ltd. (KNSA)

Role
CHIEF FINANCIAL OFFICER
Signature
/s/ Madelyn Zeylikman, Attorney-in-Fact
Issuer symbol
KNSA
Transactions as of
01 Sep 2023
Net transactions value
-$23,763
Form type
4
Filing time
06 Sep 2023, 19:06:00 UTC
Previous filing
28 Apr 2023
Next filing
04 Jan 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction KNSA Class A Common Share Options Exercise +2,695 +22% 15,109 01 Sep 2023 Direct F1
transaction KNSA Class A Common Share Tax liability $14,048 -791 -5.2% $17.76 14,318 01 Sep 2023 Direct
transaction KNSA Class A Common Share Options Exercise +1,861 +13% 16,179 02 Sep 2023 Direct F1
transaction KNSA Class A Common Share Tax liability $9,715 -547 -3.4% $17.76 15,632 02 Sep 2023 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction KNSA Restricted Share Unit Options Exercise $0 -2,695 -25% $0.000000 8,082 01 Sep 2023 Class A Common Share 2,695 Direct F1, F2
transaction KNSA Restricted Share Unit Award $0 +7,000 $0.000000 7,000 01 Sep 2023 Class A Common Share 7,000 Direct F1, F3
transaction KNSA Share Option Award $0 +42,050 $0.000000 42,050 01 Sep 2023 Class A Common Share 42,050 $17.76 Direct F4
transaction KNSA Restricted Share Unit Options Exercise $0 -1,861 -33% $0.000000 3,722 02 Sep 2023 Class A Common Share 1,861 Direct F1, F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each Restricted Share Unit (RSU) represents a contingent right to receive one Class A Common Share of the Issuer.
F2 The RSUs vest over a four-year period, with 25% of the RSUs vesting on each yearly anniversary of the date of the grant, September 1, 2022.
F3 The RSUs vest over a four-year period, with 25% of the RSUs vesting on each yearly anniversary of the date of the grant, September 1, 2023.
F4 The option vests and becomes exercisable as to 25% of the total grant on the first anniversary of the vesting commencement date and vests in 36 equal monthly installments thereafter. The vesting commencement date is September 1, 2023.
F5 The RSUs vest over a four-year period, with 25% of the RSUs vesting on each yearly anniversary of the date of the grant, September 2, 2021.